Machida, Japan

Munehiro Hashimoto

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Kasei Corporation. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Munehiro Hashimoto. Retrieved from https://idiyas.com/inventor/munehiro-hashimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Munehiro Hashimoto: Innovator in Carboxystyrene Derivatives

Introduction

Munehiro Hashimoto is a notable inventor based in Machida, Japan. He has made significant contributions to the field of chemistry, particularly in the development of carboxystyrene derivatives. His work has implications for pharmaceuticals, showcasing the intersection of innovation and healthcare.

Latest Patents

Munehiro Hashimoto holds a patent for "Carboxystyrene derivatives and drugs containing them as effective." This invention presents novel carboxystyrene derivatives of a specific general formula, which are designed to serve as effective ingredients in leukotriene antagonists and phospholipase inhibitors. The patent highlights the potential of these compounds in therapeutic applications.

Career Highlights

Hashimoto is associated with Mitsubishi Kasei Corporation, where he has been able to leverage his expertise in chemistry to drive innovation. His work at the company has positioned him as a key figure in the development of new pharmaceutical compounds.

Collaborations

Some of his notable coworkers include Yoshio Hayashi and Oguri Tomei. Their collaborative efforts contribute to the advancement of research and development within their field.

Conclusion

Munehiro Hashimoto's contributions to the field of carboxystyrene derivatives exemplify the importance of innovation in pharmaceuticals. His work not only enhances our understanding of chemical compounds but also paves the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…